BioSpace News Archive

Drug Development

Clinical Catch-Up: January 3-7

The biopharma industry has started 2022 with plenty of clinical trial news. Here’s a look.

January 7, 2022
·
10 min read
·
Mark Terry
Deals

Merck Dives Deep into AI with $610 Million+ Absci Pact

Absci Corporation inked a deal with Merck. Absci will leverage its Bionic Protein non-standard amino acid technology and AI-integrated Drug Creation Platform to create enzymes for Merck.

January 7, 2022
·
2 min read
·
Mark Terry
Tooth Regeneration Market: High Incidence of Dental Issues to Drive the Market

Tooth regeneration is a stem cell-based regenerative medical procedure that is used in tissue engineering and stem cell biology sectors.

January 7, 2022
·
5 min read
Peripherally Inserted Central Catheters Market: Increase in Prevalence of Deep Vein Thrombosis to Drive the Market

Peripherally inserted central catheters, also known as PICC, is a soft, flexible, thin tube for an intravenous line.

January 7, 2022
·
5 min read
Ocular Inserts Market: Increasing cases of retinal vascular diseases to drive the market

The demand for ocular inserts increased considerably in the past few years due to increasing incidences of glaucoma and other eye diseases.

January 7, 2022
·
5 min read
Central Nervous System Cancer Treatment Market: Rising prevalence of CNS cancer to drive the market

Central nervous system cancer tumor initiates when the cells in the spinal cord or the brain undergo uncontrollable growth forming a mass.

January 7, 2022
·
5 min read
Blood Glucose Monitors to Account for 58% of the Self-Care Medical Devices Market Value

Fact.MR – A Market Research and Competitive Intelligence Provider: As per latest Fact.MR analysis, by 2031, the global market for self-care medical devices is expected to be worth $3 billion.

January 7, 2022
·
8 min read
Bevacizumab Market: Increase in demand for personalized medicines to drive the market

Cancer is a disease which involves uncontrolled cell growth which also has potential to metastasize/spread to other parts of the body.

January 7, 2022
·
6 min read
Genetown

Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines

Sanofi and Exscientia announced a groundbreaking research collaboration and license agreement to develop up to 15 novel small molecule candidates across oncology and immunology, leveraging Exscientia’s end-to-end AI-driven platform utilizing actual patient samples.

January 7, 2022
·
8 min read
Strong Cresemba® (isavuconazole) sales by Astellas in the U.S. trigger CHF 15 million sales milestone payment to Basilea

Basilea Pharmaceutica Ltd. announced that sales of the antifungal Cresemba® by its partner Astellas Pharma Inc. in the United States exceeded the threshold triggering a milestone payment to Basilea of CHF 15 million.

January 7, 2022
·
3 min read